Sun Pharma rises on entering into license agreement with Almirall for Tildrakizumab

29 Jul 2016 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs 832.15, up by 8.35 points or 1.01% from its previous closing of Rs 823.80 on the BSE.

The scrip opened at Rs. 823.00 and has touched a high and low of Rs. 839.50 and Rs. 821.00 respectively. So far 175553 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 965.15 on 20-Aug-2015 and a 52 week low of Rs. 706.40 on 24-Nov-2015.

Last one week high and low of the scrip stood at Rs 839.50 and Rs 787.05 respectively. The current market cap of the company is Rs 200754.39 crore.

The promoters holding in the company stood at 54.97%, while Institutions and Non-Institutions held 34.96% and 10.07% respectively.

Sun Pharmaceutical Industries along with its subsidiaries or associate companies (collectively Sun Pharma) has entered into a licensing agreement with Almirall for development and commercialization of tildrakizumab for psoriasis in Europe. Tildrakizumab is an investigational IL-23p19 inhibitor currently being evaluated in patients with moderate-to-severe plaque psoriasis.

Under terms of the license agreement, Almirall will pay Sun Pharma an initial upfront payment of $50 million. Phase-3 studies of tildrakizumab have recently been completed. Sun Pharma will be eligible to receive development and regulatory milestone payments and, additionally, sales milestone payments and royalties on net sales, the terms of which are confidential.

Sun Pharma will continue to lead development of tildrakizumab for other indications, where Almirall will have right of first negotiation for certain indications in Europe. Additionally, the license agreement has a provision for possible co-promotion agreement at some point in the future, subject to certain conditions.

Sun Pharma Inds. Share Price

1729.95 -31.50 (-1.79%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×